This webinar connects people living with lupus, their care partners, and the broader community directly to Phase III clinical trials and investigational therapies with FDA Fast Track designation. Through clear, accessible information and real patient stories, attendees will learn what clinical trial participation truly involves, explore current research opportunities, and understand how clinical trials are shaping the future of lupus care—benefiting patients while advancing innovation for partners across the healthcare ecosystem.

Attendees will also have an opportunity to ask questions during the event’s Q&A portion.

Register

Thank you to our sponsors!

AstraZeneca 
 Johnson & Johnson
Novartis